What is the latest status of the project “COBRE Phase 2 Pharmaceutical Research Infrastructure”?

The status recorded for “COBRE Phase 2 Pharmaceutical Research Infrastructure” is awarded.

What is the budget and commercial profile for the project “COBRE Phase 2 Pharmaceutical Research Infrastructure”?

Taiyo normalizes the budget of “COBRE Phase 2 Pharmaceutical Research Infrastructure” to USD 11300000.

Where can I verify the source and access all details for “COBRE Phase 2 Pharmaceutical Research Infrastructure”?

This Taiyo project page references UKNow along with the original URL (https://uknow.uky.edu/research/nih-awards-uk-113-million-cobre-phase-2-pharmaceutical-research). Taiyo standardizes official data into a consistent, searchable project profile.

COBRE Phase 2 Pharmaceutical Research Infrastructure

Sector: Chemical (Industrial) • Location: Lexington, Kentucky, United States

Source: UKNow

Project

Awarded

The University of Kentucky received an $11.3 million NIH Phase 2 COBRE grant to support the COBRE for Translational Chemical Biology (CTCB). The center provides infrastructure such as the Bio Core and Chem Core, which are unique assay development, screening, and synthetic chemistry cores on campus, supporting pharmaceutical and chemical biology research.

Status: Closed
Sector: Chemical (Industrial), Education, Manufacturing (Industrial), Hospital
Location: Lexington, Kentucky, United States of America
Updated: 22 Jul 2026
Source: UKNow

ConstructChat

Ask ConstructChat about COBRE Phase 2 Pharmaceutical Research Infrastructure

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information

4 Q

The project “COBRE Phase 2 Pharmaceutical Research Infrastructure” is an infrastructure initiative in the Chemical (Industrial) sector, located in Lexington, Kentucky, United States. Taiyo aggregates data on it from UKNow.

Participants

Not available for this record.

Status

Original status	awarded
Taiyo status	Closed
Taiyo last update	2026-07-22

Contact

Not available for this record.

Description

Description	The University of Kentucky received an $11.3 million NIH Phase 2 COBRE grant to support the COBRE for Translational Chemical Biology (CTCB). The center provides infrastructure such as the Bio Core and Chem Core, which are unique assay development, screening, and synthetic chemistry cores on campus, supporting pharmaceutical and chemical biology research.
Original sector	Research
Budget

Location

Country	United States of America (USA)
State	Kentucky
City	Lexington

Source

Source	UKNow
URL

More Details

Record type	Project
Sector	Chemical (Industrial), Education, Manufacturing (Industrial), Hospital
Article published date	2026-06-01

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

Every detail on this project
News and media coverage
Technical research

View all details

Free account · no card · lands you back on this project

COBRE Phase 2 Pharmaceutical Research Infrastructure

Ask ConstructChat about COBRE Phase 2 Pharmaceutical Research Infrastructure

Project Information FAQ

Project Information

Research

View all details

More Chemical (Industrial) projects in United States